Autoimmune liver disease
- Page Path
-
- HOME
- TOPICS
- Autoimmune liver disease
- Letter to the Editor
- The major diagnostic role of autoantibodies in the diagnosis of autoimmune hepatitis, a disease of all ages
- Linda Beenet
- Clin Mol Hepatol. 2021;27(3):510-511. Published online March 22, 2021
-
View: 4521 Download: 164 Web of Science: 1 Crossref: 1
- Clinical and serological prognostic markers in primary biliary cholangitis
- Markus Wilhelmi
- Clin Mol Hepatol. 2021;27(2):360-361. Published online March 23, 2021
-
View: 4250 Download: 117
- Review
- Recent updates on the management of autoimmune hepatitis
- Atsumasa Komori
- Clin Mol Hepatol. 2021;27(1):58-69. Published online December 10, 2020
-
View: 17433 Download: 1,291 Web of Science: 81 Crossref: 93
- Current understanding of primary biliary cholangitis
- Atsushi Tanaka
- Clin Mol Hepatol. 2021;27(1):1-21. Published online December 3, 2020
-
View: 16059 Download: 891 Web of Science: 75 Crossref: 84
- Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea
- Sook-Hyang Jeong
- Clin Mol Hepatol. 2018;24(1):10-19. Published online January 5, 2018
-
View: 11926 Download: 295 Web of Science: 19 Crossref: 18
- Case Report
- Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy
- Wonyong Jo, Young-Sun Suh, Sang-Il Lee, Yun-Hong Cheon, Jeongmin Hong, Sang Su Lee, Ji Eun Kim, Gyung Hyuck Ko, Hyun-Ok Kim
- Clin Mol Hepatol. 2017;23(2):184-187. Published online May 8, 2017
-
View: 8032 Download: 119 Web of Science: 4 Crossref: 1
- Review
- The use of immunosuppression in autoimmune hepatitis: A current literature review
- Angela Cropley, Martin Weltman
- Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017
-
View: 30439 Download: 429 Web of Science: 15 Crossref: 19
- Case Report
- Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
- Seung Woon Park, Soon Ho Um, Han Ah Lee, Sang Hyun Kim, Yura Sim, Sun Young Yim, Yeon Seok Seo, Ho Sang Ryu
- Clin Mol Hepatol. 2016;22(2):281-285. Published online June 1, 2016
-
View: 12175 Download: 182 Web of Science: 9 Crossref: 10
- Original Article
- Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes
- Yoonsang Park, Yuri Cho, Eun Ju Cho, Yoon Jun Kim
- Clin Mol Hepatol. 2015;21(2):150-157. Published online June 26, 2015
-
View: 11382 Download: 168 Web of Science: 19 Crossref: 20
- Case Report
- Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines
- Hyo Jeong Oh, Young Mi Mok, Moon Seong Baek, Ji Kyeong Lee, Bong Soo Seo, Tae Hyeon Kim, Keum Ha Choi, In Kyeom Hwang, Ji Eun Ra, Yong-Reol Oh, Yong Sung Kim, Eun Young Cho, Haak Cheoul Kim, Young Woo Sohn
- Clin Mol Hepatol. 2013;19(3):305-308. Published online September 30, 2013
-
View: 12141 Download: 100 Crossref: 5
- Original Article
- Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score
- Ho Eun Jung, Jae Young Jang, Soung Won Jeong, Jin Nyoung Kim, Hee Yoon Jang, Yun Ju Cho, Sung Ae Woo, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim
- Clin Mol Hepatol. 2012;18(4):375-382. Published online December 21, 2012
-
View: 11741 Download: 67 Crossref: 8
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
